ARTICLE | Top Story
Regulus, AZN in microRNA deal
August 15, 2012 1:15 AM UTC
Regulus Therapeutics Inc. (San Diego, Calif.) and AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered to develop and commercialize preclinical microRNA therapeutics against three targets focused on cardiova...